|
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) Initiates $5 Million …
Stocks.org Under the agreement, the investor shall purchase from the company 790,514 shares of common stock and warrants to purchase up to 197,629 shares of common stock for an aggregate purchase price of $4 million and 1,000 shares of convertible preferred … Skystar Bio closes direct stock offering (SKBI)Seeking Alpha Skystar Bio-Pharmaceutical Announces $5 Million Registered Direct OfferingSYS-CON Media (press release) |
